Abstract:Background: CD4+ T cell depletion and destruction and the involution of the lymphoid tissue are hallmarks of HIV infection. Although the underlying mechanisms are still unclear, apoptosis appears to play a central role. The objective of this study was to investigate the effect of antiretroviral therapy on the lymph node tissue, particularly with respect to morphology and apoptosis. Patients and methods: Between 1997 and 1999, two inguinal lymph nodes were excised from 31 previously untreated individuals who were in an early stage of HIV infection, the first one prior to treatment and the second after 16 to 20 months of treatment. Paraffin sections were investigated for lymph node architecture, distribution of cellular and viral markers, apoptosis, and expression of apoptotic key molecules which indirectly reflect apoptotic processes. Results: After 16-20 months of antiretroviral therapy, a significant decrease in highly activated HIV-driven immune response was observed in the lymph node tissue as a marked reduction in follicular hyperplasia, a normalization of the follicular dendritic cell network, a significant increase in the number of CD4+ T cells, and a significant decrease in the number of CD8+ T cells. The expression of several proapoptotic (Fas, TRAIL, and active caspase 3) and antiapoptotic (Bcl-2 and IL-7Ralpha) molecules that were reconstituted in the tissues during therapy resembled their expression in lymph nodes of HIV-negative individuals. Limitations of the study are (a) the lack of untreated patients in the late stages, (b) for ethical reasons, the lack of a control group with untreated patients, and (c) for methodological reasons, the restriction of sequential measurements of apotpotic markers to one-third of the patients. Conclusion: Antiretroviral therapy initiated in the early stages in HIV infection may halt the irreversible destruction of the lymph node tissue and may partially normalize apoptotic processes.

Effect of HIV-1 Infection on Apoptosis of CD4+T Lymphocytes Mediated by Fas

[Immune Activation in AIDS Related Kaposi's Sarcoma].

Effect of Respiratory Syncytial Virus on Apoptosis and Expressions of FasL, Fas, Bcl-2 and Bax

Analysis of CD44 and CD95 Expression on CD4+ T Lymphocyte of HIV-1 Infected Subjects after Effective HAART

Epigenetic Mechanisms Underlying HIV-Infection Induced Susceptibility of CD4+ T Cells to Enhanced Activation-Induced FasL Expression and Cell Death

Considering Fas ligand as a target for therapy.

Apoptosis Related Proteins Expressions of T Lymphocyte in SARS Convalescent Patients

CD4 T lymphocytes are primed to express Fas ligand by CD4 cross-linking and to contribute to CD8 T-cell apoptosis via Fas/FasL death signaling pathway.

The effect of Fas/FasL's expression in hepatocellular carcinoma with HBV infection

Apoptosis and Potential Immunoregulation Mediated by Fas Molecular

Preferential Apoptosis of HIV-1-Specific CD4+ T Cells

Some findings of FADD knockdown in inhibition of HIV-1 replication in Jurkat cells and PBMCs

Apoptosis in Human Immunodeficiency Virus Infection

Modeling the effects of HIV-1 virions and proteins on Fas-induced apoptosis of infected cells

[Primary Study on Fas-mediated Apoptosis in the Liver Tissue of Patients with Chronic Hepatitis B].

Studies on the Abnormal Expression and Activation of Peripheral Lymphocyte Subsets in HIV/AIDS Patients

Effect of antiretroviral therapy on apoptosis markers and morphology in peripheral lymph nodes of HIV-infected individuals

Effect of Fas/FasL on immune/inflammation response in central nervous system

The biological effect of Fas Ligand transfected HepG2 cell

Effect of Fas Ligand Gene Transfection in Hela Cell on the Induction of Lymphocyte Apoptosis

Expression of hepatocyte apoptosis and Fas/FasL in liver tissues of patients with hepatitis D